A large and likely artifical grouping of protease domain carrying proteins related to proteasomal proteases. Only a tiny subgroup (the AFG3-related mitochondrail proteins) seem to have a TM segment.. Localization: Cytoplasmic (by homology) / Mitochondrial (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 4 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 21 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 7 |
GO:0010008 | endosome membrane | 5 | 11 |
GO:0012506 | vesicle membrane | 4 | 11 |
GO:0016020 | membrane | 2 | 11 |
GO:0030659 | cytoplasmic vesicle membrane | 5 | 11 |
GO:0031090 | organelle membrane | 3 | 11 |
GO:0031902 | late endosome membrane | 6 | 11 |
GO:0098588 | bounding membrane of organelle | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0000502 | proteasome complex | 3 | 6 |
GO:0032991 | protein-containing complex | 1 | 6 |
GO:0140535 | intracellular protein-containing complex | 2 | 6 |
GO:1902494 | catalytic complex | 2 | 6 |
GO:1905368 | peptidase complex | 3 | 6 |
GO:1905369 | endopeptidase complex | 4 | 6 |
GO:0008540 | proteasome regulatory particle, base subcomplex | 2 | 1 |
GO:0031597 | cytosolic proteasome complex | 4 | 1 |
Related structures:
AlphaFold database: Q4Q2K9
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 5 |
GO:0006807 | nitrogen compound metabolic process | 2 | 6 |
GO:0008152 | metabolic process | 1 | 6 |
GO:0009056 | catabolic process | 2 | 6 |
GO:0009057 | macromolecule catabolic process | 4 | 6 |
GO:0019538 | protein metabolic process | 3 | 6 |
GO:0030163 | protein catabolic process | 4 | 6 |
GO:0043170 | macromolecule metabolic process | 3 | 6 |
GO:0044238 | primary metabolic process | 2 | 6 |
GO:0071704 | organic substance metabolic process | 2 | 6 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 6 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 6 |
GO:1901575 | organic substance catabolic process | 3 | 6 |
GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 1 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 1 |
GO:0006950 | response to stress | 2 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010033 | response to organic substance | 3 | 1 |
GO:0010243 | response to organonitrogen compound | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010498 | proteasomal protein catabolic process | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 1 |
GO:0030433 | ubiquitin-dependent ERAD pathway | 6 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 1 |
GO:0031334 | positive regulation of protein-containing complex assembly | 6 | 1 |
GO:0033554 | cellular response to stress | 3 | 1 |
GO:0034976 | response to endoplasmic reticulum stress | 4 | 1 |
GO:0036503 | ERAD pathway | 5 | 1 |
GO:0042221 | response to chemical | 2 | 1 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 1 |
GO:0043254 | regulation of protein-containing complex assembly | 5 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0044087 | regulation of cellular component biogenesis | 4 | 1 |
GO:0044089 | positive regulation of cellular component biogenesis | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0045893 | positive regulation of DNA-templated transcription | 7 | 1 |
GO:0045898 | regulation of RNA polymerase II transcription preinitiation complex assembly | 6 | 1 |
GO:0045899 | positive regulation of RNA polymerase II transcription preinitiation complex assembly | 7 | 1 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 8 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0051128 | regulation of cellular component organization | 4 | 1 |
GO:0051130 | positive regulation of cellular component organization | 5 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051254 | positive regulation of RNA metabolic process | 6 | 1 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 1 |
GO:0051716 | cellular response to stimulus | 2 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0060260 | regulation of transcription initiation by RNA polymerase II | 8 | 1 |
GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 9 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1901698 | response to nitrogen compound | 3 | 1 |
GO:1902680 | positive regulation of RNA biosynthetic process | 7 | 1 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 8 | 1 |
GO:2000142 | regulation of DNA-templated transcription initiation | 7 | 1 |
GO:2000144 | positive regulation of DNA-templated transcription initiation | 8 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 19 |
GO:0003824 | catalytic activity | 1 | 19 |
GO:0005488 | binding | 1 | 19 |
GO:0005524 | ATP binding | 5 | 19 |
GO:0016462 | pyrophosphatase activity | 5 | 19 |
GO:0016787 | hydrolase activity | 2 | 19 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 19 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 19 |
GO:0016887 | ATP hydrolysis activity | 7 | 19 |
GO:0017076 | purine nucleotide binding | 4 | 19 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 19 |
GO:0030554 | adenyl nucleotide binding | 5 | 19 |
GO:0032553 | ribonucleotide binding | 3 | 19 |
GO:0032555 | purine ribonucleotide binding | 4 | 19 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 19 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 19 |
GO:0036094 | small molecule binding | 2 | 19 |
GO:0043167 | ion binding | 2 | 19 |
GO:0043168 | anion binding | 3 | 19 |
GO:0097159 | organic cyclic compound binding | 2 | 19 |
GO:0097367 | carbohydrate derivative binding | 2 | 19 |
GO:1901265 | nucleoside phosphate binding | 3 | 19 |
GO:1901363 | heterocyclic compound binding | 2 | 19 |
GO:0008233 | peptidase activity | 3 | 5 |
GO:0036402 | proteasome-activating activity | 2 | 6 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 5 |
GO:0140657 | ATP-dependent activity | 1 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 258 | 262 | PF00656 | 0.320 |
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.683 |
CLV_NRD_NRD_1 | 192 | 194 | PF00675 | 0.356 |
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.228 |
CLV_NRD_NRD_1 | 312 | 314 | PF00675 | 0.313 |
CLV_NRD_NRD_1 | 329 | 331 | PF00675 | 0.423 |
CLV_NRD_NRD_1 | 364 | 366 | PF00675 | 0.437 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.339 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.263 |
CLV_PCSK_KEX2_1 | 312 | 314 | PF00082 | 0.269 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 364 | 366 | PF00082 | 0.445 |
CLV_PCSK_PC1ET2_1 | 328 | 330 | PF00082 | 0.388 |
CLV_PCSK_PC7_1 | 188 | 194 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 240 | 244 | PF00082 | 0.299 |
CLV_PCSK_SKI1_1 | 252 | 256 | PF00082 | 0.299 |
CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.417 |
CLV_PCSK_SKI1_1 | 277 | 281 | PF00082 | 0.271 |
CLV_PCSK_SKI1_1 | 329 | 333 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 364 | 368 | PF00082 | 0.502 |
CLV_PCSK_SKI1_1 | 451 | 455 | PF00082 | 0.509 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 525 | 529 | PF00082 | 0.566 |
DEG_APCC_DBOX_1 | 364 | 372 | PF00400 | 0.250 |
DEG_APCC_DBOX_1 | 49 | 57 | PF00400 | 0.483 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.488 |
DOC_CKS1_1 | 126 | 131 | PF01111 | 0.502 |
DOC_CYCLIN_RxL_1 | 326 | 335 | PF00134 | 0.438 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 297 | 306 | PF00134 | 0.306 |
DOC_MAPK_gen_1 | 277 | 287 | PF00069 | 0.233 |
DOC_MAPK_gen_1 | 312 | 322 | PF00069 | 0.322 |
DOC_MAPK_HePTP_8 | 275 | 287 | PF00069 | 0.231 |
DOC_MAPK_MEF2A_6 | 278 | 287 | PF00069 | 0.299 |
DOC_MAPK_MEF2A_6 | 313 | 322 | PF00069 | 0.294 |
DOC_MAPK_NFAT4_5 | 280 | 288 | PF00069 | 0.249 |
DOC_PP1_RVXF_1 | 250 | 257 | PF00149 | 0.242 |
DOC_PP4_FxxP_1 | 184 | 187 | PF00568 | 0.439 |
DOC_SPAK_OSR1_1 | 357 | 361 | PF12202 | 0.293 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.745 |
DOC_USP7_MATH_1 | 150 | 154 | PF00917 | 0.485 |
DOC_USP7_MATH_1 | 246 | 250 | PF00917 | 0.459 |
DOC_USP7_MATH_1 | 262 | 266 | PF00917 | 0.299 |
DOC_USP7_MATH_1 | 467 | 471 | PF00917 | 0.717 |
DOC_USP7_MATH_1 | 516 | 520 | PF00917 | 0.485 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.692 |
DOC_WW_Pin1_4 | 125 | 130 | PF00397 | 0.597 |
DOC_WW_Pin1_4 | 421 | 426 | PF00397 | 0.718 |
DOC_WW_Pin1_4 | 459 | 464 | PF00397 | 0.701 |
DOC_WW_Pin1_4 | 468 | 473 | PF00397 | 0.736 |
LIG_14-3-3_CanoR_1 | 171 | 177 | PF00244 | 0.358 |
LIG_14-3-3_CanoR_1 | 277 | 287 | PF00244 | 0.233 |
LIG_14-3-3_CanoR_1 | 357 | 361 | PF00244 | 0.544 |
LIG_14-3-3_CanoR_1 | 383 | 387 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 451 | 460 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 494 | 502 | PF00244 | 0.446 |
LIG_14-3-3_CanoR_1 | 525 | 530 | PF00244 | 0.554 |
LIG_Actin_WH2_1 | 364 | 382 | PF00022 | 0.264 |
LIG_Actin_WH2_2 | 324 | 339 | PF00022 | 0.520 |
LIG_APCC_ABBAyCdc20_2 | 252 | 258 | PF00400 | 0.233 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.641 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.484 |
LIG_FHA_1 | 173 | 179 | PF00498 | 0.361 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.252 |
LIG_FHA_1 | 374 | 380 | PF00498 | 0.476 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.619 |
LIG_FHA_1 | 441 | 447 | PF00498 | 0.503 |
LIG_FHA_1 | 455 | 461 | PF00498 | 0.476 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.417 |
LIG_FHA_2 | 209 | 215 | PF00498 | 0.271 |
LIG_FHA_2 | 340 | 346 | PF00498 | 0.500 |
LIG_FHA_2 | 383 | 389 | PF00498 | 0.528 |
LIG_FHA_2 | 426 | 432 | PF00498 | 0.690 |
LIG_FHA_2 | 516 | 522 | PF00498 | 0.540 |
LIG_GBD_Chelix_1 | 275 | 283 | PF00786 | 0.382 |
LIG_LIR_Apic_2 | 182 | 187 | PF02991 | 0.350 |
LIG_LIR_Gen_1 | 315 | 323 | PF02991 | 0.327 |
LIG_LIR_Gen_1 | 355 | 366 | PF02991 | 0.395 |
LIG_LIR_Gen_1 | 376 | 386 | PF02991 | 0.532 |
LIG_LIR_Gen_1 | 67 | 78 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 315 | 320 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 355 | 361 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 376 | 381 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 498 | 504 | PF02991 | 0.556 |
LIG_LIR_Nem_3 | 67 | 73 | PF02991 | 0.524 |
LIG_Pex14_1 | 157 | 161 | PF04695 | 0.456 |
LIG_Pex14_2 | 310 | 314 | PF04695 | 0.271 |
LIG_PTAP_UEV_1 | 128 | 133 | PF05743 | 0.476 |
LIG_SH2_CRK | 197 | 201 | PF00017 | 0.336 |
LIG_SH2_CRK | 31 | 35 | PF00017 | 0.547 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.420 |
LIG_SH2_STAP1 | 66 | 70 | PF00017 | 0.582 |
LIG_SH2_STAP1 | 76 | 80 | PF00017 | 0.524 |
LIG_SH2_STAT5 | 438 | 441 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.620 |
LIG_SH3_2 | 187 | 192 | PF14604 | 0.432 |
LIG_SH3_2 | 472 | 477 | PF14604 | 0.526 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.520 |
LIG_SH3_3 | 184 | 190 | PF00018 | 0.425 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.503 |
LIG_SH3_3 | 317 | 323 | PF00018 | 0.276 |
LIG_SH3_3 | 368 | 374 | PF00018 | 0.369 |
LIG_SH3_3 | 466 | 472 | PF00018 | 0.526 |
LIG_SUMO_SIM_anti_2 | 401 | 409 | PF11976 | 0.499 |
LIG_TRAF2_1 | 519 | 522 | PF00917 | 0.452 |
LIG_TYR_ITIM | 29 | 34 | PF00017 | 0.399 |
MOD_CDC14_SPxK_1 | 424 | 427 | PF00782 | 0.536 |
MOD_CDC14_SPxK_1 | 474 | 477 | PF00782 | 0.486 |
MOD_CDK_SPK_2 | 463 | 468 | PF00069 | 0.520 |
MOD_CDK_SPxK_1 | 421 | 427 | PF00069 | 0.543 |
MOD_CDK_SPxK_1 | 471 | 477 | PF00069 | 0.483 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.617 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.340 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.409 |
MOD_CK1_1 | 321 | 327 | PF00069 | 0.279 |
MOD_CK1_1 | 390 | 396 | PF00069 | 0.672 |
MOD_CK1_1 | 452 | 458 | PF00069 | 0.668 |
MOD_CK1_1 | 459 | 465 | PF00069 | 0.696 |
MOD_CK1_1 | 471 | 477 | PF00069 | 0.497 |
MOD_CK1_1 | 480 | 486 | PF00069 | 0.669 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.271 |
MOD_CK2_1 | 425 | 431 | PF00069 | 0.694 |
MOD_CK2_1 | 452 | 458 | PF00069 | 0.534 |
MOD_CK2_1 | 515 | 521 | PF00069 | 0.490 |
MOD_CK2_1 | 71 | 77 | PF00069 | 0.445 |
MOD_DYRK1A_RPxSP_1 | 468 | 472 | PF00069 | 0.514 |
MOD_GlcNHglycan | 121 | 125 | PF01048 | 0.601 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.252 |
MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.365 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.350 |
MOD_GlcNHglycan | 395 | 398 | PF01048 | 0.702 |
MOD_GlcNHglycan | 454 | 457 | PF01048 | 0.530 |
MOD_GlcNHglycan | 508 | 511 | PF01048 | 0.603 |
MOD_GlcNHglycan | 518 | 521 | PF01048 | 0.520 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.444 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.612 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.382 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.378 |
MOD_GSK3_1 | 421 | 428 | PF00069 | 0.652 |
MOD_GSK3_1 | 452 | 459 | PF00069 | 0.535 |
MOD_GSK3_1 | 463 | 470 | PF00069 | 0.685 |
MOD_GSK3_1 | 477 | 484 | PF00069 | 0.583 |
MOD_GSK3_1 | 512 | 519 | PF00069 | 0.663 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.449 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.564 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.278 |
MOD_NEK2_1 | 297 | 302 | PF00069 | 0.368 |
MOD_NEK2_1 | 379 | 384 | PF00069 | 0.373 |
MOD_NEK2_1 | 420 | 425 | PF00069 | 0.617 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.381 |
MOD_PK_1 | 433 | 439 | PF00069 | 0.514 |
MOD_PKA_2 | 356 | 362 | PF00069 | 0.469 |
MOD_PKA_2 | 379 | 385 | PF00069 | 0.489 |
MOD_PKA_2 | 388 | 394 | PF00069 | 0.618 |
MOD_PKA_2 | 467 | 473 | PF00069 | 0.526 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.435 |
MOD_Plk_1 | 76 | 82 | PF00069 | 0.377 |
MOD_Plk_2-3 | 356 | 362 | PF00069 | 0.432 |
MOD_Plk_4 | 179 | 185 | PF00069 | 0.470 |
MOD_Plk_4 | 292 | 298 | PF00069 | 0.320 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.427 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.505 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.692 |
MOD_ProDKin_1 | 125 | 131 | PF00069 | 0.592 |
MOD_ProDKin_1 | 421 | 427 | PF00069 | 0.718 |
MOD_ProDKin_1 | 459 | 465 | PF00069 | 0.703 |
MOD_ProDKin_1 | 468 | 474 | PF00069 | 0.738 |
MOD_SUMO_for_1 | 279 | 282 | PF00179 | 0.233 |
MOD_SUMO_rev_2 | 8 | 15 | PF00179 | 0.514 |
TRG_DiLeu_BaEn_1 | 100 | 105 | PF01217 | 0.443 |
TRG_DiLeu_BaEn_1 | 17 | 22 | PF01217 | 0.437 |
TRG_DiLeu_BaLyEn_6 | 190 | 195 | PF01217 | 0.322 |
TRG_DiLeu_BaLyEn_6 | 327 | 332 | PF01217 | 0.435 |
TRG_DiLeu_BaLyEn_6 | 362 | 367 | PF01217 | 0.423 |
TRG_DiLeu_BaLyEn_6 | 415 | 420 | PF01217 | 0.527 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.231 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.486 |
TRG_ENDOCYTIC_2 | 504 | 507 | PF00928 | 0.480 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.504 |
TRG_ER_diArg_1 | 191 | 193 | PF00400 | 0.395 |
TRG_ER_diArg_1 | 277 | 279 | PF00400 | 0.228 |
TRG_ER_diArg_1 | 311 | 313 | PF00400 | 0.261 |
TRG_ER_diArg_1 | 329 | 331 | PF00400 | 0.227 |
TRG_ER_diArg_1 | 363 | 365 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 529 | 532 | PF00400 | 0.515 |
TRG_NES_CRM1_1 | 274 | 288 | PF08389 | 0.365 |
TRG_NLS_Bipartite_1 | 312 | 332 | PF00514 | 0.301 |
TRG_Pf-PMV_PEXEL_1 | 277 | 282 | PF00026 | 0.429 |
TRG_Pf-PMV_PEXEL_1 | 330 | 335 | PF00026 | 0.452 |
TRG_Pf-PMV_PEXEL_1 | 39 | 44 | PF00026 | 0.564 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P643 | Leptomonas seymouri | 49% | 100% |
A0A0S4JAU3 | Bodo saltans | 30% | 80% |
A0A1X0P9Z1 | Trypanosomatidae | 40% | 100% |
A0A3Q8IIF1 | Leishmania donovani | 94% | 99% |
A0A3S5H547 | Leishmania donovani | 34% | 100% |
A0A422NNS9 | Trypanosoma rangeli | 45% | 100% |
A4H3L6 | Leishmania braziliensis | 33% | 100% |
A4H6T6 | Leishmania braziliensis | 30% | 100% |
A4HB54 | Leishmania braziliensis | 75% | 100% |
A4HME8 | Leishmania braziliensis | 36% | 100% |
A4IAA1 | Leishmania infantum | 94% | 99% |
C9ZLZ3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9ACJ9 | Leishmania major | 34% | 100% |
E9AG43 | Leishmania infantum | 34% | 100% |
E9AJT7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9B5C4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
O17071 | Caenorhabditis elegans | 29% | 100% |
P62333 | Homo sapiens | 28% | 100% |
P62334 | Mus musculus | 28% | 100% |
P62335 | Ictidomys tridecemlineatus | 28% | 100% |
V5B5D2 | Trypanosoma cruzi | 42% | 100% |